Zimmer Biomet Holdings (ZBH): The stock had negative money flow to the tune of ($1.91 million) on Thursday, which shows that the traders are selling the stock on the price strength. The inflow of money on upticks was $24.69 million, whereas, the outflow of money on downticks was $26.6 million and the ratio between the two was 0.93. The block trade had a negative net money flow of ($0.97 million). The total block trade value undertaken on upticks was $3.65 million. On the other hand, downticks amounted to $2.68 million of the traded value, which shows distribution in the stock by traders. The ratio between uptick and downtick was 1.36. Zimmer Biomet Holdings (ZBH) closed with marginal gains of 31 cents to end the day at $122.09, an increase of 0.25% over the previous days close. The stock recorded 1.17% for the week.
Zimmer Biomet Holdings (ZBH) : The highest level Zimmer Biomet Holdings (ZBH) is projected to reach is $135 for the short term and the lowest estimate is at $105. The consolidated price target from 14 rating analysts who initiate coverage on the stock is $129 and the possibility the share price can swing is $8.34. The stock has recorded a 20-day Moving Average of 3.07% and the 50-Day Moving Average is 3.11%.
Zimmer Biomet Holdings (NYSE:ZBH): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $121.60 and $121.58 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $122.80. The buying momentum continued till the end and the stock did not give up its gains. It closed at $122.02, notching a gain of 0.20% for the day. The total traded volume was 1,483,580 . The stock had closed at $121.78 on the previous day.
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.